Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Asian Nat Prod Res ; 24(1): 15-23, 2022 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-33779429

RESUMO

Liver cirrhosis and hepatocellular carcinoma are the late stage of liver fibrosis. How to early use drugs to intervene in liver fibrosis is a prerequisite for the reversal of liver fibrosis. This paper mainly introduces a cell signaling transduction pathway in liver fibrosis and the intervention of natural products in order to provide theoretical basis for the treatment of liver fibrosis.


Assuntos
Produtos Biológicos , Neoplasias Hepáticas , Produtos Biológicos/farmacologia , Humanos , Cirrose Hepática/tratamento farmacológico , Estrutura Molecular , Transdução de Sinais
2.
Curr Med Sci ; 41(2): 228-235, 2021 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-33877539

RESUMO

Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) with unknown origin spread rapidly to 222 countries, areas or territories. To investigate the genomic evolution and variation in the early phase of COVID-19 pandemic in Guangdong, 60 specimens of SARS-CoV-2 were used to perform whole genome sequencing, and genomics, amino acid variation and Spike protein structure modeling analyses. Phylogenetic analysis suggested that the early variation in the SARS-CoV-2 genome was still intra-species, with no evolution to other coronaviruses. There were one to seven nucleotide variations (SNVs) in each genome and all SNVs were distributed in various fragments of the genome. The Spike protein bound with human receptor, an amino acid salt bridge and a potential furin cleavage site were found in the SARS-CoV-2 using molecular modeling. Our study clarified the characteristics of SARS-CoV-2 genomic evolution, variation and Spike protein structure in the early phase of local cases in Guangdong, which provided reference for generating prevention and control strategies and tracing the source of new outbreaks.


Assuntos
COVID-19/genética , Evolução Molecular , SARS-CoV-2/crescimento & desenvolvimento , Glicoproteína da Espícula de Coronavírus/genética , COVID-19/epidemiologia , COVID-19/virologia , China/epidemiologia , Furina/genética , Genoma Viral/genética , Humanos , Pandemias , Filogenia , Ligação Proteica/genética , SARS-CoV-2/patogenicidade
3.
Toxicol In Vitro ; 25(8): 1654-63, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-21767629

RESUMO

Zearalenone (ZEN) is commonly found in many food commodities and is known to cause reproductive disorders and genotoxic effects. However, the mode of ZEN-induced cell death of macrophages and the mechanisms by which ZEN causes cytotoxicity remain unclear. The present study shows that ZEN treatment reduces viability of RAW264.7 cells in a dose-dependent manner. ZEN causes predominantly necrotic and late apoptotic cell death. ZEN treatment also results in the loss of mitochondrial membrane potential (MMP), mitochondrial changes in Bcl-2 and Bax proteins, and cytoplasmic release of cytochrome c and apoptosis-inducing factor (AIF). Pre-treatment of the cells with either z-VAD-fmk or z-IETD-fmk does not attenuate ZEN-mediated cell death, whereas catalase suppresses the ZEN-induced decrease in viability in RAW264.7 cells. Treating the cells with c-Jun N-terminal kinase (JNK), p38 mitogen-activated protein kinase (MAPK), or p53 inhibitor prevented ZEN-mediated changes, such as MMP loss, cellular reactive oxygen species (ROS) increase, and cell death. JNK or p38 MAPK inhibitor inhibited mitochondrial alterations of Bcl-2 and Bax proteins with attendant decreases in cellular ROS levels. Knockdown of AIF via siRNA transfection also diminished ZEN-induced cell death. Further, adenosine triphosphate was markedly depleted in the ZEN-exposed cells. Collectively, these results suggest that ZEN induces cytotoxicity in RAW264.7 cells via AIF- and ROS-mediated signaling, in which the activations of p53 and JNK/p38 play a key role.


Assuntos
Fator de Indução de Apoptose/metabolismo , Sistema de Sinalização das MAP Quinases/efeitos dos fármacos , Necrose/induzido quimicamente , Espécies Reativas de Oxigênio/metabolismo , Zearalenona/toxicidade , Trifosfato de Adenosina/metabolismo , Animais , Apoptose/efeitos dos fármacos , Linhagem Celular , Citocromos c/metabolismo , Proteínas Quinases JNK Ativadas por Mitógeno/metabolismo , Potencial da Membrana Mitocondrial/efeitos dos fármacos , Camundongos , Mitocôndrias/efeitos dos fármacos , Mitocôndrias/fisiologia , Necrose/metabolismo , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Proteína Supressora de Tumor p53/metabolismo , Proteína X Associada a bcl-2/metabolismo , Proteínas Quinases p38 Ativadas por Mitógeno/metabolismo
4.
Zhong Yao Cai ; 32(12): 1807-10, 2009 Dec.
Artigo em Chinês | MEDLINE | ID: mdl-20432894

RESUMO

OBJECTIVE: To evaluate the efficiency of 4 Odorrana grahami antimicrobial peptides from skin against 5 pathogenic bacteria, include 2 wild strains and 7 resistant strains. METHODS: Broth microdilution antimicrobial susceptibility test was used for bacteria that growed aerobically. RESULTS: The 4 Odorrana grahami antimicrobial peptides were basically in vitro efficient agents for inhibition against to methicillin-resistant coagulase negative Staphylococcus (MRSCN, 85460), wild Staphylococcus aureus (24157), penicillin-resistant Streptococcus pneumoniae (PRSP, 84688 and 91452), class I beta-lactamase Enterobacter cloacae (AmpC, 85439 and 93543), wild Escherichia coli (84492), extended-spectrum beta-lactamases Escherichia coli (ESBL, 84492), inhabitor-resistant TEM beta-lactamase Escherichia coli (IRT, 85580). CONCLUSION: The 4 Odorrana grahami antimicrobial peptides from skin have broad spectrum antimicrobial activity; especially have in vitro activity to resistant strains. So it is hopeful to be developed as the antimicrobial agent as well as the disinfectant and the antiseptic.


Assuntos
Peptídeos Catiônicos Antimicrobianos/farmacologia , Bactérias/efeitos dos fármacos , Materia Medica/farmacologia , Ranidae , Pele/química , Animais , Peptídeos Catiônicos Antimicrobianos/isolamento & purificação , Farmacorresistência Bacteriana , Enterococcus/efeitos dos fármacos , Bactérias Gram-Negativas/efeitos dos fármacos , Materia Medica/isolamento & purificação , Testes de Sensibilidade Microbiana , Sensibilidade e Especificidade , Pele/metabolismo , Staphylococcus/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...